Physician profile
Michael A Eigenberg
NPI 1780845107
$2,818.30
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,326 · 2020: $121 · 2021: $189 · 2022: $140 · 2023: $42.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $42.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $42.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien Lp | $1,759.23 | 2019 | |
| W. L. Gore & Associates, INC. | $322.39 | 2019 | |
| Smith+Nephew, INC. | $311.72 | 2021-2023 | Collagenase Santyl |
| Intuitive Surgical, INC. | $161.30 | 2019 | |
| Organogenesis INC. | $64.36 | 2020-2021 | |
| Integra Lifesciences Corporation | $43.96 | 2020-2022 | |
| Shire North American Group INC | $31.13 | 2019 | |
| Kci USA, INC. | $27.37 | 2023 | V.A.C. Dermatac, Activ.A.C. |
| Mallinckrodt Enterprises LLC | $19.20 | 2019 | |
| Mallinckrodt Hospital Products INC. | $18.75 | 2020 | |
| Bard Peripheral Vascular, INC. | $17.23 | 2019 | |
| Boston Scientific Corporation | $15.49 | 2019 | |
| Medtronic USA, INC. | $14.33 | 2020 | |
| Lsi Solutions INC | $11.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Eigenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.